¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"excitatory junctional potential"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • evoked potential
    À¯¹ßÀüÀ§
  • early receptor potential
    Á¶±â¼ö¿ëüÀüÀ§, Á¶±â½Ã°¢¼¼Æ÷ÀüÀ§
  • electric potential
    Àü±âÀüÀ§, ÀüÀ§
  • electric potential gradient
    ÀüÀ§±â¿ï±â
  • electrochemical potential
    Àü±âÈ­ÇÐÀüÀ§
  • electrochemical potential gradient
    Àü±âÈ­ÇÐÀüÀ§±â¿ï±â
  • electrode potential
    Àü±ØÀüÀ§
  • electrotonic potential
    Àü±â±äÀåÀüÀ§
  • endocochlear potential
    ´ÞÆØÀ̳»ÀüÀ§, ¿Í¿ì³»ÀüÀ§
  • endplate potential
    Á¾¸»ÆÇÀüÀ§, Á¾ÆÇÀüÀ§
  • fasciculation potential
    ±Ù(À°)¼¶À¯´Ù¹ß¼öÃàÀüÀ§
  • fibrillation potential
    ¼¶À¯ÀÚ¹ßÀüÀ§
  • generator potential
    ¹ß»ý±âÀüÀ§, ±âµ¿ÀüÀ§
  • giant potential
    °Å´ëÀüÀ§
  • inhibitory postsynaptic potential
    ¾ïÁ¦½Ã³ÀÀÌÈÄÀüÀ§, ¾ïÁ¦¿¬Á¢ÀÌÈÄÀüÀ§
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • potential difference
    Àü¾ÐÂ÷, ÀüÀ§Â÷
  • total potential energy difference
    ÃÑÀ§Ä¡¿¡³ÊÁöÂ÷
  • transmembrane potential difference
    ¸·ÀüÀ§Â÷ÀÌ
  • early receptor potential
    Á¶±â½Ã°¢¼¼Æ÷ÀüÀ§
  • electric potential
    ˟ˤ
  • electric potential gradient
    ÀüÀ§±â¿ï±â
  • electrochemical potential
    Àü±âÈ­ÇÐÀüÀ§
  • electrochemical potential gradient
    Àü±âÈ­ÇÐÀüÀ§±â¿ï±â
  • electrode potential
    Àü±ØÀüÀ§
  • electrotonic potential
    Àü±â±äÀåÀüÀ§
  • end plate potential
    Á¾ÆÇÀüÀ§, Á¾¸»ÆÇÀüÀ§
  • endocochlear potential
    ¿Í¿ì³»ÀüÀ§
  • evoked potential
    À¯¹ßÀüÀ§
  • potential energy
    À§Ä¡¿¡³ÊÁö, ÀüÀ§¿¡³ÊÁö
  • fibrillation potential
    Àܶ³¸²ÀüÀ§, ¼¼µ¿ÀüÀ§
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • potential
    ˟ˤ
  • potential acuity meter
    ÀáÀç½Ã·ÂÃøÁ¤±â
  • potential barrier
    ÀüÀ§À庮
  • potential difference
    Àü¾ÐÂ÷, ÀüÀ§Â÷.
  • presynaptic potential
    ½Ã³³½ºÀüÀüÀ§.
  • receptor potential
    ¼ö¿ë±âÀüÀ§.
  • redox potential
    »êȭȯ¿øÀüÀ§(ß«ûùü»êª ï³êÈ).
  • reduction potential
    ȯ¿øÀüÀ§.
  • reinnervation potential
    ½Å°æÀçÁö¹èÀüÀ§(ãêÌèî¢ò¨ÛÕï³êÈ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • auditory evoked potential
    û°¢ [û¼º]À¯¹ßÀüÀ§
  • axon potential
    ̈ȏ˟ˤ
  • body surface potential mapping
    üǥ¸é ÀüÀ§µµ(ô÷øúØüï³êÈÓñ).
  • chemical potential
    È­ÇÐÆ÷ÅÙ¼³.
  • chemical potential
    È­ÇÐÀüÀ§ (¡­ï³êÈ)
  • cochlear action potential
    ¿Í¿ì Ȱµ¿ÀüÀ§
  • complex potential
    º¹ÇÕÀüÀ§(¡­ï³êÈ).
  • complex potential
    º¹ÇÕÀüÀ§
  • compound action potential
    º¹ÇÕ È°µ¿Àü¾Ð(ÜÜùêüÁÔÑï³äâ)
  • compound action potential
    º¹ÇÕȰµ¿Àü¾Ð(ÜÜùêüÀÔÑï³äâ).
  • corneoretinal potential
    °¢¸·¸Á¸·ÀüÀ§
  • cortical evoked potential = CE
    ÇÇÁúÀ¯¹ßÀüÀ§.
  • cortical evoked potential =CEP
    ÇÇÁúÀ¯¹ßÀüÀ§(ù«òõë¯Û¡ï³êÈ).
  • cortical evoked potential =CEP
    ÇÇÁúÀ¯¹ßÀüÀ§.
  • critical membrane potential
    ÀӰ踷Àü¾Ð(×üͣحï³äâ).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • phosphate transfer potential
    ÀλêÀüÀÌ ÀüÀ§(×òß«ï®ì¹ï³êÈ)
  • phosphorylation potential
    ÀλêÈ­ ÀüÀ§(×òß«ûùï³êÈ)
  • phosphoryl transfer potential
    ÀλêÈ­ ÀüÀÌ ÀüÀ§(×òß«ûùï®ì¹ï³êÈ)
  • potential
    "ÀüÀ§(ï³êÈ), Æ÷ÅÙ¼È"
  • potential difference
    ÀüÀ§Â÷(ï³êÈó¬)
  • potential-drop method
    ÀüÀ§ °­ÇϹý(ï³êÈ˽ù»Ûö)
  • potential energy barrier
    "ÀüÀ§(ï³êÈ) ¿¡³ÊÁö À庮(î¡Ûú), ÆÛÅÙ¼È ¿¡³ÊÁö À庮"
  • potential energy diagram
    "ÀüÀ§(ï³êÈ) ¿¡³ÊÁö µµÇü(Óñû¡), ÆÛÅÙ¼È ¿¡³ÊÁö µµÇü(Óñû¡)"
  • potential energy well
    "ÀüÀ§(ï³êÈ) ¿¡³ÊÁö ¿ì¹°, ÆÛÅÙ¼È ¿¡³ÊÁö ¿ì¹°"
  • potential gradient
    "ÀüÀ§ ±¸¹è(ï³êÈÎþÛÕ), ÆÛÅÙ¼È ±¸¹è(ÎþÛÕ)"
  • potential mediator
    "ÀüÀ§ ¸Å°³ÀÚ(ï³êÈØÚË¿íº), ÆÛÅÙ¼È ¸Å°³ÀÚ(ØÚË¿íº)"
  • potential well
    ÀüÀ§(ï³êÈ) ¿ì¹°
  • proton transfer potential
    ¾ç¼ºÀÚ(åÕàõí­) ÀüÀÌ ÀüÀ§(ï®ì¹ï³êÈ)
  • redox potential
    ·¹µ¶½º ÀüÀ§(ï³êÈ)
  • reduction potential
    ȯ¿ø ÀüÀ§(ü½êªï³êÈ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
EPSC excitatory postsynaptic current
AEP acute edematous pancreatitis; artificial endocrine pancreas; auditory evoked potential; average evok...
AP accessory pathway; accounts payable; acid phosphatase; acinar parenchyma; action potential; active p...
ERP early receptor potential; effective refractory period; elodoisin-related peptide; endoscopic retrogr...
FAP familial adenomatous polyposis; familial amyloid polyneuropathy; fatty acid polyunsaturated; fatty a...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
H-JEB Herlitz junctional epidermolysis bullosa
JAM Junctional Adhesion Molecule
JE Junctional Epithelium
JEB Junctional epidermolysis bullosa
J-SR Junctional sarcoplasmic reticulum
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • positive after potential
    ¾ç¼º ÈÄÀüÀ§
  • potential complication
    °¡´ÉÇÑ ÇÕº´Áõ, ÀáÀçÀû ÇÕº´Áõ
  • potential damage
    ÀáÀçÀû ¼Õ»ó
  • potential energy
    À§Ä¡ ¿¡³ÊÁö
  • potential for surgical failure
    ¿Ü°úÀû Ä¡·áÀÇ ½ÇÆÐ °¡´É¼º
  • potential pollutant
    ÀáÀç ¿À¿°¹°
  • potential temperature
    ¿ÂÀ§
  • presynaptic potential
    ½Ã³³½ºÀü ÀüÀ§
  • receptor potential
    ¼ö¿ë±â ÀüÀ§
    ÀÏÁ¤ÇÑ ¹°¸®È­ÇÐÀû Àڱؿ¡ ´ëÇÏ¿© ½Å°æ ´ÜÀ§ ¼ö¿ëü¿¡¼­ ¹ß»ýÇÏ´Â Å»ºÐ±Ø.
  • resting potential
    Á¤Áö ÀüÀ§
  • reversal potential
    ¿ªÀü Àü¾Ð
  • rheobasic potential
    ±âÀü¾Ð
  • somatosensory evoked potential
    ü¼º °¨°¢ ¹ßÀüÀ§
  • synaptic potential
    ½Ã³³½º ÀüÀ§
  • threshold membrane potential
    ¹®Åθ·Àü, ¿ªÄ¡¸· ÀüÀ§
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
body surface potential mapping Recording of regional electrophysiological information by analysis of surface potentials to give a complete picture of the effects of the currents from the heart on the body surface. It has been applied to the diagnosis of old inferior myocardial infarction, localization of the bypass pathway in wolff-parkinson-white syndrome, recognition of ventricular hypertrophy, estimation of the size of a myocardial infarct, and the effects of different interventions designed to reduce infarct size. The limiting factor at present is the complexity of the recording and analysis, which requires 100 or more electrodes, sophisticated instrumentation, and dedicated personnel.
(12 Dec 1998)
brain potential <physiology> The electrical charge of the brain as compared to a point on the body; the potential may be steady (DC potential) or may fluctuate at specific frequencies when recorded against time, giving rise to the electroencephalogram.
(05 Mar 2000)
pacemaker potential The voltage inscribed by impulses from an artificial electronic pacemaker.
(05 Mar 2000)
generator potential Local depolarisation of the membrane potential at the end of a sensory neurone in graded response to the strength of a stimulus applied to the associated receptor organ, e.g., a pacinian corpuscle; if the generator potential becomes large enough (because the stimulus is at least of threshold strength), it causes excitation at the nearest node of Ranvier and a propagated action potential.
(05 Mar 2000)
receptor potential The transmembrane potential difference of a sensory cell. Such cells are not generally excitable, but their response to stimulation is a gradual change in their resting potential.
(18 Nov 1997)
redox potential <chemistry> The reducing/oxidizing power of a system measured by the potential at a hydrogen electrode.
(18 Nov 1997)
reduction potential The inherent tendency of a compound to act as an electron donor or an electron acceptor. Measured in volts.
(09 Oct 1997)
visual evoked potential Voltage fluctuations that may be recorded from the occipital area of the scalp as the result of retinal stimulation by a light flashing at 1/4-second intervals; commonly summated and averaged by computer.
(05 Mar 2000)
cell potential <cell biology, physiology> The voltage of an electrochemical cell, the larger the cell potential, the greater the extent of reaction when equilibrium is reached.
(26 Mar 1998)
resting potential <physiology> The electrical potential of the inside of a cell, relative to its surroundings. Almost all animal cells are negative inside, resting potentials are in the range 20 to 100mV, 70mV typical.
Resting potentials reflect the action of the sodium pump only indirectly, they are mainly caused by the subsequent diffusion of potassium out of the cell through potassium leak channels. The resting potential is thus close to the Nernst potential for potassium.
See: action potential.
(10 Mar 1998)
membrane potential <physiology> More correctly, transmembrane potential difference: the electrical potential difference across a plasma membrane.
See: resting potential, action potential.
(18 Nov 1997)
chemical potential <chemistry> The work required (in j mol 1) to bring a molecule from a standard state (usually infinitely separated in a vacuum) to a specified concentration.
More usually employed as chemical potential difference, the work required to bring one mole of a substance from a solution at one concentration to another at a different concentration, __ = RT.In (c2/cl). This definition is useful in studies of active transport, note that, for charged molecules, the electrical potential difference must also be considered (see electrochemical potential).
(18 Nov 1997)
miniature end plate potential <physiology> Small fluctuations (typically 0.5 mV) in the resting potential of postsynaptic cells.
They are the same shape as, but much smaller than, the end plate potentials caused by stimulation of the presynaptic cell. Miniature end plate potentials are considered as evidence for the quantal release of neurotransmitters at chemical synapses, a single miniature end plate potential resulting from the release of the contents of a single synaptic vesicle.
(12 Jan 1998)
water potential <plant biology> The chemical potential (i.e. Free energy per mole) of water in plants. Water moves within plants from regions of high water potential to regions of lower water potential, i.e. Down gradient.
(18 Nov 1997)
myogenic potential Action potential of muscle.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á